Capacitive Biosensors for Ultrasensitive Analyses.

Posted by

SELECTBIO

MDx at point of care at competitive costs remains an unmatched task which is mostly defined by the requirement of molecular detection technologies for highly processed and pure samples. We addressed this task at the level of sensitivity, specificity, and kinetics of the implemented biochip technologies.